Matinas BioPharma Hldgs Stock (AMEX: MTNB) stock price, news, charts, stock research, profile.
You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG) and Qualigen Therapeutics (NASDAQ:QLGN).
Matinas BioPharma Hldgs has a consensus price target of $3.00.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.588 last updated January 2, 2025 at 4:10 PM EST.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q4 earnings are confirmed for Wednesday, March 26, 2025.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.